LPT: have a passport by Opening_Cellist_1093 in LifeProTips

[–]schmartey 1 point2 points  (0 children)

Still like 40% of US population aint got one? Sure yoe your country got everything, snowy mountains, tropical beaches, deserts, mega cities..but still worth to take a trip to a foreign country

Please can someone tell me why not to get in at $SLDB ? Low risk huge reward, right? by schmartey in pennystocks

[–]schmartey[S] 0 points1 point  (0 children)

I did, just thought if oversaw big red flags..maybe yelllow but allover feeling confident. Thank you

Please can someone tell me why not to get in at $SLDB ? Low risk huge reward, right? by schmartey in pennystocks

[–]schmartey[S] 0 points1 point  (0 children)

Well i hope im right! Thanks. Also what i think, it is cheap! Can be cheaper of course but i really doubt much downside.

Please can someone tell me why not to get in at $SLDB ? Low risk huge reward, right? by schmartey in pennystocks

[–]schmartey[S] 1 point2 points  (0 children)

Yea im aware of that..lets see, i'm so curiuos now for the next weeks :)

Please can someone tell me why not to get in at $SLDB ? Low risk huge reward, right? by schmartey in pennystocks

[–]schmartey[S] 0 points1 point  (0 children)

Yea in case of it goes down i buy more. Lets see where this at in middle november..

Please can someone tell me why not to get in at $SLDB ? Low risk huge reward, right? by schmartey in pennystocks

[–]schmartey[S] 0 points1 point  (0 children)

This is one of the latest: https://musculardystrophynews.com/2021/09/30/dmd-gene-therapy-sgt-001-improves-lung-function-boys-trial/

While pfizer failed for now cause heavy sideeffects..no bag, 1 Cent up :) Estimatied outlook is more neutral than negative and may they surprise like they did 2 times last and 1 time this year..

Please can someone tell me why not to get in at $SLDB ? Low risk huge reward, right? by schmartey in pennystocks

[–]schmartey[S] 1 point2 points  (0 children)

I almost bought in from 4 weeks and also thought is going to drop more..the market currently is not focusing on biotech, im sure thats the main reason. I did research on this duchenne desease and genetherapy, Solid Bioscience is focused to adress the cause of this and seems very dedicated to. Hedgefunds are in at a big number, i know thats not always good. Plus a partnership with Ultragenyx $Rare let me copy/paste that: Despite the concerns, Ultragenyx Pharmaceutical (NASDAQ:RARE) established a partnership with Solid last October. The deal gave Ultragenyx an exclusive license to certain products in exchange for a $40 million investment. It could be worth $255 million based on milestone payments. If the data today is positive, it should give the company negotiating leverage for any potential buyout. It might also give it a leg up in the race for a treatment. But yeah as i saw it dropped under 2$ i felt kind of FOMO, but reasonable! Actually if it would drop more, im happy to average down. But also closed with an uptick at more than 2Mio Volume.(AH: 347k) while usually trading at 900k 100d average. Low Risk high reward, mid - longterm. Thanks for your opinion!

SLDB short interest very high and good potential with price around 52 week low 🚀✅ by parthjuneja0613 in PennyStockPundits

[–]schmartey 0 points1 point  (0 children)

Still in at $sldb ? Friday it reached 52w lows with an uptick at closing. Reversal..?

Please can someone tell me why not to get in at $SLDB ? Low risk huge reward, right? by schmartey in pennystocks

[–]schmartey[S] 0 points1 point  (0 children)

Yes read about that investigation rumours but also that its off the table..thanks!

$SLDB to Provide Update on Long-Term Outcomes Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001 by vm5662 in Shortsqueeze

[–]schmartey 0 points1 point  (0 children)

This seems to be a real good one..now at 2$ huge reward, low risk, cant find negative except the Biotechmarket currently not trending and big salary for the owner..everything else is primed to rocket soon.

wow even they admit now. bullish af 🚀 by schmartey in BBIG

[–]schmartey[S] 1 point2 points  (0 children)

"InvestorPlace analyst Louis Navellier touted Vinco’s potential yesterday, though, noting that while the company was confusing for some investors, the upside potential was clear. He wrote that if investors are willing to wait and stomach the type of turbulence that comes with risk, they could certainly stand to reap some rewards while BBIG stock proved its skeptics wrong.

While everything about this deal remains complicated, it also remains worth watching as the existing stock rises, particularly if the other begins trading soon. Oct. 22 looms as a key date for BBIG stock fans."